Quarterly report pursuant to Section 13 or 15(d)

Schedule of Diluted Net Income (Loss) Per Share (Details)

v3.21.2
Schedule of Diluted Net Income (Loss) Per Share (Details) - shares
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total contingent shares issuance arrangement, stock options or warrants 228,656,441 202,075,134
Convertible Debt Securities [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total contingent shares issuance arrangement, stock options or warrants 25,406,041 12,461,539
Common Stock Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total contingent shares issuance arrangement, stock options or warrants 21,380,865 7,063,919
Share-based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total contingent shares issuance arrangement, stock options or warrants 170,035 850,176
Series A Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total contingent shares issuance arrangement, stock options or warrants 1,300,000 1,300,000
Series C Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total contingent shares issuance arrangement, stock options or warrants 180,399,500 180,399,500